Abstract
Tyrosine kinases often play pivotal roles in the pathogenesis of cancer and are good candidates for therapeutic intervention and targeted molecular imaging. The precursor synthesis, radiosynthesis, and biological characterization of a fluorine-18 analog of dasatinib, a multitargeted kinase inhibitor, are reported. Compound 5 potently inhibits Abl, Src, and Kit kinases and inhibits K562 and M07e/p210bcr-abl human leukemic cell growth. Using positron emission tomography, we visualized K562 tumor xenografts in mice with [18F]-5.
| Original language | English |
|---|---|
| Pages (from-to) | 5853-5857 |
| Number of pages | 5 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 50 |
| Issue number | 23 |
| DOIs | |
| State | Published - 15 Nov 2007 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver